Tracker › Companies › BioAtla, Inc.
4 No sign of it. We found no public evidence tying BioAtla, Inc.'s cuts to AI.
Every tracked 2026 layoff at BioAtla, Inc., newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 4/100 (Minimal) · 80% interval 4–5 · evidence grade D · US · Pharma / Chemicals
Stated reason: On March 2, 2026, the Company announced a workforce reduction of approximately 70%. The foregoing actions were committed to on February 24, 2026 and are intended to further cost-containment measures in connection with the Company’s formal process to explore and evaluate strategic options to maximize shareholder value. The total cash payments related to this workforce reduction are estimated to be between $0.5 and $0.…
Why 4: Merger / acquisition integration · Drivers: industry AI exposure +0.5, contrary evidence −0.2
Evidence: SEC filing. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.653, industry exposure 0.712, AI investment 0.0, contrary evidence 0.15 · typical Health Care & Pharma roles (no roles named)
Headcount basis: not disclosed
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Health Care & Pharma layoffs we track.
Health Care & Pharma · 738 workers
Health Care & Pharma · 322 workers
Health Care & Pharma · 250 workers
Health Care & Pharma · 108 workers
Health Care & Pharma · 85 workers
Health Care & Pharma
